2 Monster Stocks to Buy Without Any Hesitation
While the phrase "monster stocks" might generally have investors thinking of Tesla, Apple, or similar behemoths, the two businesses discussed in this article are sneakily monstrous.
First, consumer health juggernaut Kenvue (NYSE: KVUE) produces and markets seven No. 1 global brands. And in less than a year since its spinoff from an actual monster stock, Johnson Johnson, its dividend yield has ballooned to 4.2%.
Meanwhile, (NYSE: RMD), a leader in continuous positive airway pressure (CPAP) machines, has delivered enormous total returns of over 24,000% since its initial public offering (IPO) in 1995.
Source Fool.com
Resmed Inc. Aktie
200,10 €
2,26 %
Die Resmed Inc. Aktie ist ein klarer Community-Favorit: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Kursziel von 215 € für Resmed Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 200.1 €.
